Research Collaboration for a Precision Oncology Program (POP)

Launched by ANDREAS WICKI · Nov 6, 2024

Keywords

ClinConnect Summary

The Precision Oncology Program (POP) is a clinical trial designed to learn more about the specific characteristics of tumors in patients with advanced cancer. By using advanced technologies and comparing patient data, the researchers hope to find out which treatments might work best for individuals based on their unique tumor biology. This study is currently looking for participants of all genders, aged 65 and older, who have been diagnosed with solid tumors, such as adenocarcinoma or sarcoma. Unfortunately, patients with blood cancers are not eligible to join.

If you decide to participate, you will need to sign a consent form to confirm your willingness to be part of the study. You will also have the opportunity to understand the procedures involved, including how your medical information may be shared with external partners, while ensuring your privacy is protected. The goal of this trial is not only to gather valuable information about cancer treatments but also to help improve future care for patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed informed consent
• • In the case of deceased persons: signed general consent
• • All patients with the diagnosis of a solid tumour including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, sarcoma, etc
• • ECOG-performance status 0-2, if applicable
• • Willing and able to understand all project related procedures, including transfer of coded (i.e. pseudonymised) or anonymized clinical data to external partners (e.g. Roche), if applicable
• Exclusion Criteria:
• • Patients with the diagnosis of blood cancer.